Rachel Esler

946 total citations
42 papers, 618 citations indexed

About

Rachel Esler is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Rachel Esler has authored 42 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 14 papers in Urology. Recurrent topics in Rachel Esler's work include Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (17 papers) and Urological Disorders and Treatments (9 papers). Rachel Esler is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (17 papers) and Urological Disorders and Treatments (9 papers). Rachel Esler collaborates with scholars based in Australia, United Kingdom and Qatar. Rachel Esler's co-authors include John Yaxley, Matthew J. Roberts, Nigel Dunglison, Geoff Coughlin, Robert A. Gardiner, Andrew Morton, Peter Donato, Sheliyan Raveenthiran, Patrick Telöken and Patrick N. A. Harris and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Urology.

In The Last Decade

Rachel Esler

39 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Esler Australia 12 458 163 156 97 75 42 618
Raju Chelluri United States 12 313 0.7× 71 0.4× 117 0.8× 130 1.3× 28 0.4× 36 486
Andrea Guttilla Italy 12 589 1.3× 298 1.8× 155 1.0× 207 2.1× 15 0.2× 34 777
Ariê Carneiro Brazil 14 465 1.0× 49 0.3× 157 1.0× 145 1.5× 22 0.3× 63 622
Patrick T. Gomella United States 11 626 1.4× 190 1.2× 205 1.3× 133 1.4× 10 0.1× 27 761
S Conquy France 11 552 1.2× 103 0.6× 204 1.3× 233 2.4× 79 1.1× 48 802
Mahesha Weerakoon Australia 7 429 0.9× 42 0.3× 142 0.9× 120 1.2× 39 0.5× 12 471
A. Méjean France 13 346 0.8× 73 0.4× 41 0.3× 156 1.6× 27 0.4× 52 516
Gregg Eure United States 12 492 1.1× 55 0.3× 193 1.2× 160 1.6× 33 0.4× 35 687
Carmen Maccagnano Italy 17 504 1.1× 51 0.3× 161 1.0× 221 2.3× 11 0.1× 31 816
Adam Calaway United States 14 276 0.6× 30 0.2× 107 0.7× 325 3.4× 48 0.6× 67 614

Countries citing papers authored by Rachel Esler

Since Specialization
Citations

This map shows the geographic impact of Rachel Esler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Esler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Esler more than expected).

Fields of papers citing papers by Rachel Esler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Esler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Esler. The network helps show where Rachel Esler may publish in the future.

Co-authorship network of co-authors of Rachel Esler

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Esler. A scholar is included among the top collaborators of Rachel Esler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Esler. Rachel Esler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Rhee, Handoo, Sheliyan Raveenthiran, Anita Pelecanos, et al.. (2024). The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort. European Urology Focus. 10(5). 770–778. 4 indexed citations
4.
Patel, Nishal, Nigel Dunglison, Rachel Esler, et al.. (2023). Uro-symphyseal Fistula: A Systematic Review to Inform a Contemporary, Evidence-based Management Framework. Urology. 178. 1–8. 4 indexed citations
5.
Rhee, Handoo, Sheliyan Raveenthiran, Rhiannon McBean, et al.. (2023). Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management. European Journal of Nuclear Medicine and Molecular Imaging. 51(1). 295–303. 4 indexed citations
6.
Graves, Bianca, David L. Paterson, Patrick N. A. Harris, et al.. (2022). Guideline of guidelines: management of recurrent urinary tract infections in women. British Journal of Urology. 130(S3). 11–22. 71 indexed citations
7.
Rhee, Handoo, Simon Wood, Sheliyan Raveenthiran, et al.. (2022). Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT). Urologic Oncology Seminars and Original Investigations. 40(6). 276.e1–276.e9. 11 indexed citations
8.
9.
10.
Roberts, Matthew J., Andrew Morton, Peter Donato, et al.. (2020). 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(2). 477–482. 66 indexed citations
11.
Nouhaud, François‐Xavier, Marc S. Williams, William Yaxley, et al.. (2020). Robot-assisted orthotopic “W” ileal neobladder in male patients: step-by-step video-illustrated technique and preliminary outcomes. Journal of Robotic Surgery. 14(5). 739–744. 2 indexed citations
12.
Roberts, Matthew J., Andrew Morton, Peter Donato, et al.. (2020). Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(2). 655–656. 2 indexed citations
13.
Donato, Peter, Andrew Morton, John Yaxley, et al.. (2020). 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?. European Journal of Nuclear Medicine and Molecular Imaging. 47(8). 1843–1851. 70 indexed citations
14.
Donato, Peter, Andrew Morton, John Yaxley, et al.. (2019). Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital. World Journal of Urology. 38(2). 371–379. 24 indexed citations
15.
Raveenthiran, Sheliyan, et al.. (2019). The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 46(11). 2280–2288. 59 indexed citations
16.
Nouhaud, François‐Xavier, Michael Williams, Marlon Perera, et al.. (2018). Is postoperative Doppler ultrasonography useful for the early detection of asymptomatic pseudoaneurysm and prevention of haemorrhagic complications after partial nephrectomy?. British Journal of Urology. 122(S5). 15–21. 6 indexed citations
17.
Donato, Peter, Matthew J. Roberts, Andrew Morton, et al.. (2018). Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. European Journal of Nuclear Medicine and Molecular Imaging. 46(1). 20–30. 85 indexed citations
18.
Yaxley, William, et al.. (2018). Review and update of benign prostatic hyperplasia in general practice. Australian Journal of General Practice. 47(7). 471–475. 8 indexed citations
19.
Bromage, Stephen J., Helene Thygesen, Rachel Esler, et al.. (2015). The changes in prostate cancer and its management in the North West of England over a 10-year period. Journal of Clinical Urology. 8(5). 315–320. 1 indexed citations
20.
Esler, Rachel, Stephen J. Bromage, Neil Oakley, et al.. (2013). Diethylstilboestrol for the treatment of prostate cancer: past, present and future. Scandinavian Journal of Urology. 48(1). 4–14. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raju Chelluri Breakdown of academic impact, for papers by Andrea Guttilla Breakdown of academic impact, for papers by Ariê Carneiro Breakdown of academic impact, for papers by Patrick T. Gomella Breakdown of academic impact, for papers by S Conquy Breakdown of academic impact, for papers by Mahesha Weerakoon Breakdown of academic impact, for papers by A. Méjean Breakdown of academic impact, for papers by Gregg Eure Breakdown of academic impact, for papers by Carmen Maccagnano Breakdown of academic impact, for papers by Adam Calaway
Rankless by CCL
2026